Potential impact of novel diagnostics and treatments on the burden of antibiotic resistant in Escherichia coli
Pierre Nouvellet, J.V. Robotham, N.R. Naylor, N. Woodford, Neil M. Ferguson
The paper estimates the burden of E. coli bloodstream infections in Europe and assesses how novel diagnostics and treatments could reduce mortality and hospital stays.
bioRxiv · May 13, 2016 · PreprintEpidemiology